You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

Article metrics

Article menu
Download PDFPDF
Epidemiology
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity

 

Online download statistics by month:

Online download statistics by month: July 2021 to April 2023

AbstractFullPdf
Jul 202118361802690
Aug 202125842542659
Sep 202119401862475
Oct 202114171360352
Nov 2021924878266
Dec 2021784752202
Jan 2022656640212
Feb 2022524514148
Mar 2022461460173
Apr 2022419405143
May 2022324319122
Jun 202228326174
Jul 2022306292101
Aug 202228127183
Sep 202239538686
Oct 202227926960
Nov 202225524049
Dec 202220619642
Jan 202318316754
Feb 202317116146
Mar 202316816043
Apr 2023355138
Total14751139504088